News

Sesame Workshop - India and Viatris Inc. Launch Animated Videos & Other Resources to Help Indian Families Address Socio-Emotional Needs Through the Pandemic

Dec 8, 2020

The Council of Scientific & Industrial Research (CSIR) and Mylan Announce Partnership to Advance Therapeutic Options for Management of COVID – 19

Sep 23, 2020

Mylan Secures DCGI Approval in India for Pretomanid, a Treatment for Highly Drug-Resistant Forms of Tuberculosis

Jul 22, 2020

Mylan Initiates Supply of Remdesivir in India, Under Brand Name DESREM^™

Jul 20, 2020

Mylan Secures Regulatory Approval for Remdesivir Lyophilized Powder for Injection 100 mg/vial in India for Restricted Emergency Use in COVID-19 Patients

Jul 6, 2020

Eisai India and Mylan Enter into Co-Exclusive Marketing Agreement to Commercialize Teceris^® the Second Eribulin Brand in India

Sep 25, 2019

Winners of the 2018 Mylan Hackathon announced

Oct 16, 2018

Mylan launches Saugella^® in India

Feb 26, 2018

Mylan Launches HepBest in India

Dec 7, 2017

Mylan launches Healthy Liver Healthy Delhi program

Dec 6, 2017

Mylan Launches Biosimilar Bevacizumab, ABEVMY^®, in India

Nov 27, 2017

Mylan Launches DURART R 450

Nov 17, 2017

Mylan Launches Avonza in India

Aug 9, 2017

Mylan Launches MyHep All^TM in India

Jul 27, 2017

Mylan Health Hackathon to Focus on Delivering Better Health for a Better World

Mar 8, 2016

On World AIDS Day, Mylan Announces Plans to be the First to Market Newly-Recommended Antiretroviral Treatment for $99 Per Patient, Per Year

Dec 1, 2015

Mylan Completes Acquisition of Certain Businesses from Famy Care to Create a Leading Women's Healthcare Franchise

Nov 20, 2015

Mylan Launches Gilead Sciences’ Sovaldi® Tablets in India

May 4, 2015

Mylan Launches Generic Sofosbuvir Tablets, MyHep^TM, in India

Apr 23, 2015